Sustained symptomatic, functional, and hemodynamic benefit with the selective endothelin-A receptor antagonist, sitaxsentan, in patients with pulmonary arterial hypertension: a 1-year follow-up study (Q45108419)
Jump to navigation
Jump to search
scientific article published in October 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Sustained symptomatic, functional, and hemodynamic benefit with the selective endothelin-A receptor antagonist, sitaxsentan, in patients with pulmonary arterial hypertension: a 1-year follow-up study |
scientific article published in October 2004 |
Statements
1 reference
Sustained symptomatic, functional, and hemodynamic benefit with the selective endothelin-A receptor antagonist, sitaxsentan, in patients with pulmonary arterial hypertension: a 1-year follow-up study (English)
1 reference
David Langleben
1 reference
Andrew M Hirsch
1 reference
Eileen Shalit
1 reference
Lyda Lesenko
1 reference
Robyn J Barst
1 reference
1 October 2004
1 reference
1 reference
126
1 reference
4
1 reference
1377-1381
1 reference
Identifiers
1 reference
1 reference